source
- GSK, Ionis unveil data for hepatitis B drug touted as ‘functional cure’The findings supporting bepirovirsen were deemed a “historic moment” by physicians and validate a drug that has “clear blockbuster potential,” according to one analyst.BioPharma Dive · 2mo ago↗ source
- For wearables, it’s a GLP-1 worldWe have two pieces of wearables-related news for you today, and (maybe unsurprisingly) GLP-1s came up in our conversations with both companies. First, Signos raised $20 million for its approach ...Endpoints · 2mo ago↗ source
- CVS obesity drug deal puts Lilly on equal footing with NovoThe agreement includes Lilly’s new pill Foundayo and restores coverage for Zepbound, erasing what had been a commercial edge for rival Novo Nordisk.BioPharma Dive · 2mo ago